Thomas P. Majewski bought $100k of EIIA
Chief Executive Officer at Eagle Point Institutional Income Fund. 4,000 shares at an average of $24.96, traded Oct 23, 2024, filed Oct 24, 2024.
Score components
- +25RoleCEO
- +10Trade size$100k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +1.2%, 3m +2.3%, 6m +3.0%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001617694-24-000001, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 23, 2024 | POpen-market purchase 8.125% Series A Term Preferred Shares due 2029 | +4,000 | $24.96 | $100k | 4,000 | Oct 24, 2024 |
Related signals
Other insiders at Eagle Point Institutional Income Fund and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 48Moderate | EIIAbuy Eagle Point Institutional Income Fund | Thomas P. Majewski Chief Executive Officer | $25k 3,019 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.